nodes	percent_of_prediction	percent_of_DWPC	metapath
Ridogrel—TBXAS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.0546	0.0546	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0458	0.0458	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.0415	0.0415	CbGpPWpGaD
Ridogrel—TBXA2R—Thromboxane A2 receptor signaling—RAC1—dilated cardiomyopathy	0.037	0.037	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.036	0.036	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.0338	0.0338	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.0317	0.0317	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.0306	0.0306	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (12/13) signalling events—RAC1—dilated cardiomyopathy	0.0293	0.0293	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TTN—dilated cardiomyopathy	0.0214	0.0214	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0192	0.0192	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.0191	0.0191	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—ACTN2—dilated cardiomyopathy	0.0185	0.0185	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.0179	0.0179	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0173	0.0173	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.0171	0.0171	CbGpPWpGaD
Ridogrel—TBXA2R—Thromboxane A2 receptor signaling—EGFR—dilated cardiomyopathy	0.0168	0.0168	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.0165	0.0165	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.0165	0.0165	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—VCL—dilated cardiomyopathy	0.0158	0.0158	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0153	0.0153	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ANKRD1—dilated cardiomyopathy	0.015	0.015	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.0148	0.0148	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.0148	0.0148	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—TAZ—dilated cardiomyopathy	0.0141	0.0141	CbGpPWpGaD
Ridogrel—TBXA2R—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.014	0.014	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.0135	0.0135	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.0131	0.0131	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—SDHA—dilated cardiomyopathy	0.0128	0.0128	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.0127	0.0127	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.0126	0.0126	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.0126	0.0126	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.0123	0.0123	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.012	0.012	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.012	0.012	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.0117	0.0117	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0113	0.0113	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00966	0.00966	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00916	0.00916	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00892	0.00892	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00836	0.00836	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.00818	0.00818	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—ITGB1—dilated cardiomyopathy	0.00791	0.00791	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.0078	0.0078	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.0076	0.0076	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.0071	0.0071	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.0071	0.0071	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00684	0.00684	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00679	0.00679	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—CD36—dilated cardiomyopathy	0.00675	0.00675	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.0066	0.0066	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00644	0.00644	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00644	0.00644	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00639	0.00639	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—RAC1—dilated cardiomyopathy	0.00636	0.00636	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00599	0.00599	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.0058	0.0058	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00573	0.00573	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00546	0.00546	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00518	0.00518	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00495	0.00495	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.0047	0.0047	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00429	0.00429	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—RAF1—dilated cardiomyopathy	0.00422	0.00422	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00402	0.00402	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00384	0.00384	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00381	0.00381	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00381	0.00381	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00365	0.00365	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00354	0.00354	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00349	0.00349	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GPX1—dilated cardiomyopathy	0.00347	0.00347	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00343	0.00343	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CD36—dilated cardiomyopathy	0.00338	0.00338	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—AGT—dilated cardiomyopathy	0.00305	0.00305	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00293	0.00293	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00278	0.00278	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00242	0.00242	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00239	0.00239	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00216	0.00216	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AGT—dilated cardiomyopathy	0.00206	0.00206	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00166	0.00166	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00143	0.00143	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00098	0.00098	CbGpPWpGaD
